HEPCVIR (Sofosbuvir) tablets manufactured by Cipla. HEPCVIR tablets of Cipla contains Sofosbuvir 400mg.
Hepcvir tablets of Cipla is indicated for the treatment of chronic hepatitis C (CHC) in adults.
Hepcvir tablets of Cipla available in a bottle of 15 tablets.
Hepcvir (Sofosbuvir) of Cipla is a breakthrough treatment for Hepatitis C infections. Hepcvir (Sofosbuvir) of Cipla mechanism of action involves inhibiting the enzyme which is necessary for the virus if it is to multiply. A complete cure may even be possible. Chronic hepatitis C is a serious infection of the liver which occurs following an infection with the hepatitis C virus. Upon reaching the cells of the liver, the virus begins to multiply, which it achieves by means of copying its DNA and RNA. Hepcvir (Sofosbuvir) of Cipla is known as a nucleotide polymerase inhibitor, and it works directly on the virus itself. Hepcvir (Sofosbuvir) of Cipla are film coated tablets each contain 400mg of the main ingredient. The dosage of Hepcvir (Sofosbuvir) of Cipla schedule must be individualized by the physician in charge of treatment, and will vary according to the viral genotype that is being treated. Adult patients will usually be directed by their physician to take 1 tablet of Hepcvir (Sofosbuvir) of Cipla per day, and it can be administered alongside a meal or else without food. Precautions Patients who are undergoing treatment for Hepatitis C with Hepcvir (Sofosbuvir) of Cipla will require regular visits to their physician or the hospital so that routine blood tests can be carried out. The frequency at which these tests are required will be determined by your physician.